Search Results - "Meşe, Şermin Güven"

Dermatological side effects of immunotherapy drugs and targeted cancer therapies: Importance of dermatology and oncology collaboration by Çelik, Uğur, Aydemir, Ertuğrul H, Engin, Burhan, Oba, Muazzez Ç, Yılmaz, Mesut, Meşe, Şermin Güven

“…Introduction Novel anti-cancer drugs such as targeted cancer therapies and immune check-point inhibitors (ICIs) have adverse events, especially concerning the…”
Get full text

Interobserver and intraobserver agreement on prostate-specific membrane antigen PET/CT images according to the miTNM and PSMA-RADS criteria by Demirci, Emre, Akyel, Reşit, Caner, Biray, Alan-Selçuk, Nalan, Güven-Meşe, Şermin, Ocak, Meltem, Kabasakal, Levent

“…AIMIn this study, we aimed to measure interobserver and intraobserver agreement in Ga-68–prostate-specific membrane antigen (PSMA) PET/computed tomography (CT)…”
Get full text

Treatment exceeds expectations with vemurafenib monotherapy in a patient with BRAFV600E-mutant metastatic melanoma by Yilmaz, Mesut, Güven Meşe, Şermin

“…Introduction Patients with distant metastatic melanoma has a poor prognosis, with a reported median survival time of six to eight months. In modern era,…”
Get full text

Treatment exceeds expectations with vemurafenib monotherapy in a patient with BRAF V600E -mutant metastatic melanoma by Yilmaz, Mesut, Güven Meşe, Şermin

“…Patients with distant metastatic melanoma has a poor prognosis, with a reported median survival time of six to eight months. In modern era, survival has…”
Get full text

Durable response after discontinuation of nivolumab therapy in the absence of disease progression or toxicity with two advanced NSCLC patients by Yilmaz, Mesut, Guven Mese, Sermin

“…Background Nivolumab is an immune checkpoint inhibitor that selectively blocks the programmed cell death-1 (PD-1). Nowadays, immune checkpoint inhibitors such…”
Get full text

Nivolumab-induced lichen planus by Yilmaz, Mesut, Mese, Sermin Guven, Celik, Ugur

“…Introduction Renal cell carcinomas account for 90% of all malignant neoplasms of the kidney. The most common types of renal cancer in adults are clear cell and…”
Get full text

An advanced c-MET-amplified NSCLC patient that was treated with crizotinib by Yilmaz, Mesut, Mese, Sermin Guven, Cil, Ibrahim, Zirtiloglu, Alisan

“…Introduction c-MET is a tyrosine kinase receptor, which is encoded in part by mesenchymal-epidermal transition (MET) exon 14. Mutations in the MET gene can…”
Get full text